Login / Signup

The regulatory role of N<sup>6</sup> -methyladenosine modification in the interaction between host and microbes.

Ruhao ZhuoMenghui XuXiaoyun WangBin ZhouXin WuVanessa LeoneEugene B ChangXiang Zhong
Published in: Wiley interdisciplinary reviews. RNA (2022)
N<sup>6</sup> -methyladenosine (m<sup>6</sup> A) is the most prevalent posttranscriptional modification in eukaryotic mRNAs. Dynamic and reversible m<sup>6</sup> A modification regulates gene expression to control cellular processes and diverse biological functions. Growing evidence indicated that m<sup>6</sup> A modification is involved in the homeostasis of host and microbes (mostly viruses and bacteria). Disturbance of m<sup>6</sup> A modification affects the life cycles of viruses and bacteria, however, these microbes could in turn change host m<sup>6</sup> A modification leading to human disease including autoimmune diseases and cancer. Thus, we raise the concept that m<sup>6</sup> A could be a "messenger" molecule to participate in the interactions between host and microbes. In this review, we summarize the regulatory mechanisms of m<sup>6</sup> A modification on viruses and commensal microbiota, highlight the roles of m<sup>6</sup> A methylation in the interaction of host and microbes, and finally discuss drugs development targeting m<sup>6</sup> A modification. This article is categorized under: RNA in Disease and Development &gt; RNA in Disease.
Keyphrases
  • gene expression
  • dna methylation
  • endothelial cells
  • transcription factor
  • squamous cell carcinoma
  • drug delivery
  • genome wide
  • young adults
  • cancer therapy
  • sensitive detection
  • drug induced
  • quantum dots